J del Campo

Author PubWeight™ 3.77^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	New vaccines require potent adjuvants like AFPL1 and AFCo1.	Scand J Immunol	2007	1.07
2	Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer.	Eur J Cancer	2009	1.02
3	A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer.	Int J Gynecol Cancer	2006	0.91
4	[Analysis of the experience of diabetes mellitus through case study: an approach to patient's quality of life].	Med Clin (Barc)	2000	0.77
5	Chalicogloea cavernicola gen. nov., sp. nov. (Chroococcales, Cyanobacteria), from low-light aerophytic environments: combined molecular, phenotypic and ecological criteria.	Int J Syst Evol Microbiol	2012	0.75
6	Changes of environment and darkness enhance the NADPH-diaphorase staining in the rat paraventricular nucleus.	Neuropeptides	1999	0.75
7	[Myotomy of the lower constrictor in total laryngectomy with phonatory prosthesis. Our experience].	Acta Otorrinolaringol Esp	1990	0.75